Literature DB >> 14581435

Extravasations of oxaliplatin.

Albrect Kretzschmar, Daniel Pink, Peter Thuss-Patience, Bernd Dörken, Peter Reichert, Robert Eckert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14581435     DOI： 10.1200/JCO.2003.99.095

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Overview, prevention and management of chemotherapy extravasation.

Authors:  Firas Y Kreidieh; Hiba A Moukadem; Nagi S El Saghir
Journal:  World J Clin Oncol       Date:  2016-02-10

2.  A midline for oxaliplatin infusion: the myth of safety devices.

Authors:  Ben Masters; Tamas Hickish; Esther Uña Cidon
Journal:  BMJ Case Rep       Date:  2014-06-05

Review 3.  Management of the extravasation of anti-neoplastic agents.

Authors:  J Boulanger; A Ducharme; A Dufour; S Fortier; K Almanric
Journal:  Support Care Cancer       Date:  2015-02-26       Impact factor: 3.603

4.  Cervical dissecting extravasation of oxaliplatin: A case report.

Authors:  Jorge Hernando; Judit Riera-Arnau; Maria Roca; Alejandro Garcia; Jaume Capdevila
Journal:  Mol Clin Oncol       Date:  2022-01-12

5.  Extravasation of oxaliplatin: an infrequent and irritant toxicity.

Authors:  C Pericay; A López; J R Soler; T Bonfill; E Dotor; E Saigí
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.